Greene Condemns Vaccine Approval: “Not MAHA at All”
Congresswoman Marjorie Taylor Greene criticized the FDA’s approval of Moderna’s new lower-dose COVID-19 vaccine, mNEXSPIKE, deeming it inconsistent with Robert F. Kennedy Jr.’s “Make America Healthy Again” initiative. The vaccine, approved for high-risk individuals aged 12 and older, follows a Phase 3 clinical trial and aims to combat ongoing COVID-19 threats. This announcement comes amidst shifting CDC guidance on COVID-19 vaccination for pregnant women and healthy children, a change welcomed by Kennedy Jr. Moderna’s CEO lauded the approval as adding a crucial tool in protecting vulnerable populations.
John Q. Hosedrinker